These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25133279)

  • 1. Intravenous thrombolysis in stroke patients receiving rivaroxaban.
    Seiffge DJ; Traenka C; Gensicke H; Tsakiris DA; Bonati LH; Peters N; Lyrer P; Engelter ST
    Eur J Neurol; 2014; 21(1):e3-4. PubMed ID: 25133279
    [No Abstract]   [Full Text] [Related]  

  • 2. Rivaroxaban and other novel anticoagulants for stroke prevention in atrial fibrillation: time to embrace the future.
    Rajappan K
    Heart; 2013 Mar; 99(6):361-2. PubMed ID: 23024007
    [No Abstract]   [Full Text] [Related]  

  • 3. Dissolution of the left atrial appendage thrombus with rivaroxaban therapy.
    Takasugi J; Yamagami H; Okata T; Toyoda K; Nagatsuka K
    Cerebrovasc Dis; 2013; 36(4):322-3. PubMed ID: 24192983
    [No Abstract]   [Full Text] [Related]  

  • 4. Rivaroxaban in acute coronary syndromes and atrial fibrillation: rivaroxaban shown to reduce cardiovascular deaths in STEMI patients.
    Aalbers J
    Cardiovasc J Afr; 2012 Oct; 23(9):525-6. PubMed ID: 23108522
    [No Abstract]   [Full Text] [Related]  

  • 5. New anticoagulants (dabigatran, apixaban, rivaroxaban) for stroke prevention in atrial fibrillation.
    Aguilar MI; Kuo RS; Freeman WD
    Neurol Clin; 2013 Aug; 31(3):659-75. PubMed ID: 23896498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Summaries for patients. Rivaroxaban in patients transitioned from vitamin K antagonist therapy.
    Ann Intern Med; 2013 Jun; 158(12):I-28. PubMed ID: 23778921
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical outcomes with rivaroxaban in patients transitioned from vitamin K antagonist therapy: a subgroup analysis of a randomized trial.
    Mahaffey KW; Wojdyla D; Hankey GJ; White HD; Nessel CC; Piccini JP; Patel MR; Berkowitz SD; Becker RC; Halperin JL; Singer DE; Califf RM; Fox KA; Breithardt G; Hacke W
    Ann Intern Med; 2013 Jun; 158(12):861-8. PubMed ID: 23778903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rivaroxaban for stroke prevention in atrial fibrillation and secondary prevention in patients with a recent acute coronary syndrome.
    Ahrens I; Bode C
    Future Cardiol; 2012 Jul; 8(4):533-41. PubMed ID: 22871192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention and therapy of thromboembolism: rivaroxaban - better outcome - risk profile as standard therapy].
    MMW Fortschr Med; 2013 Sep; 155(15):56-7. PubMed ID: 24224377
    [No Abstract]   [Full Text] [Related]  

  • 10. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
    Lip GY; Larsen TB; Skjøth F; Rasmussen LH
    J Am Coll Cardiol; 2012 Aug; 60(8):738-46. PubMed ID: 22575324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of rivaroxaban compared to warfarin for stroke prevention in atrial fibrillation.
    Lee S; Anglade MW; Pham D; Pisacane R; Kluger J; Coleman CI
    Am J Cardiol; 2012 Sep; 110(6):845-51. PubMed ID: 22651881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raft of rivaroxaban good news from the USA, implications for South African clinical practice.
    Cardiovasc J Afr; 2011; 22(6):345-6. PubMed ID: 22159327
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
    Harenberg J; Marx S; Diener HC; Lip GY; Marder VJ; Wehling M; Weiss C
    Int Angiol; 2012 Aug; 31(4):330-9. PubMed ID: 22801398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rivaroxaban in prevention of stroke in patients with atrial fibrillation].
    Simonyi G; Medvegy M
    Ideggyogy Sz; 2012 Nov; 65(11-12):365-8. PubMed ID: 23289170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rivaroxaban and stroke prevention in patients with atrial fibrillation: new evidence.
    Martínez-Rubio A; Dan GA; Kaski JC
    Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):933-47. PubMed ID: 24948333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
    Mantha S; Ansell J
    Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rivaroxaban for stroke prevention in atrial fibrillation: a critical review of the ROCKET AF trial.
    Paikin JS; Manolakos JJ; Eikelboom JW
    Expert Rev Cardiovasc Ther; 2012 Aug; 10(8):965-72. PubMed ID: 23030284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke prevention in patients with atrial fibrillation: focus on new oral anticoagulants.
    Toth PP
    Postgrad Med; 2013 May; 125(3):155-61. PubMed ID: 23748516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel oral anticoagulants in non-valvular atrial fibrillation.
    Potpara TS; Lip GY
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):115-29. PubMed ID: 23953900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New oral anticoagulants in elderly patients.
    Barco S; Cheung YW; Eikelboom JW; Coppens M
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):215-24. PubMed ID: 23953909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.